Loading…
Curanex Pharmaceuticals Inc is projected to decline to $0.2006 by 2027, a -10% move from its current price of $0.2228. CURX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.2132 | $0.2227 | $0.2328 | -0.03% |
| Jul 14 | $0.2092 | $0.2227 | $0.237 | -0.06% |
| Jul 15 | $0.2063 | $0.2226 | $0.2402 | -0.08% |
| Jul 16 | $0.2038 | $0.2226 | $0.243 | -0.11% |
| Jul 17 | $0.2016 | $0.2225 | $0.2455 | -0.14% |
| Jul 18 | $0.1997 | $0.2224 | $0.2477 | -0.17% |
| Jul 19 | $0.1979 | $0.2224 | $0.2498 | -0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.1979 | $0.2224 | $0.2498 | -0.19% |
| Week 2 | $0.1882 | $0.2219 | $0.2616 | -0.39% |
| Week 3 | $0.1811 | $0.2215 | $0.271 | -0.58% |
| Week 4 | $0.1752 | $0.2211 | $0.279 | -0.78% |
| Week 5 | $0.1701 | $0.2206 | $0.2862 | -0.97% |
| Week 6 | $0.1656 | $0.2202 | $0.2929 | -1.16% |
| Week 7 | $0.1615 | $0.2198 | $0.2991 | -1.35% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Curanex Pharmaceuticals Inc is a developmental stage healthcare company that discovers, develops, and commercializes botanical drugs to treat inflammatory diseases.
Its Phyto-N program targets multiple therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout.
The company was formerly known as Fordman Pharma Inc and adopted the name Curanex Pharmaceuticals Inc in November 2023. It was founded in 1996 and is headquartered in Jericho, New York.
CURX is a healthcare asset currently trading at $0.2102.
It has a market capitalization of $5.96M and is ranked 5268 by market cap.
The price outlook is mixed in the near term, with a 2026 average of $0.2102 and a 2030 average of $0.2334, rising toward higher levels in later years (2040 average $0.2999; 2050 average $0.6164) and a 2050 max of $1.42. The forecast also shows a near-term range from a 2026 min of $0.21 to a max of $0.2703, and note the 2030 max of $0.43 and 2040 max of $0.6898.
A major floor 43.6% below — a decisive break under it would weaken the trend.
The nearest floor, 5.7% below — buyers have tended to step in here.
The nearest ceiling, 53.9% above — a clean break opens room to run.
A major ceiling 137.4% above — clearing it would confirm fresh momentum.
Key CURX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CURX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.2206 | Buy | $0.2251 | Sell |
| MA 10 | $0.2429 | Sell | $0.2396 | Sell |
| MA 20 | $0.2719 | Sell | $0.2627 | Sell |
| MA 50 | $0.3093 | Sell | $0.309 | Sell |
| MA 100 | $0.3702 | Sell | $0.423 | Sell |
| MA 200 | $0.4359 | Sell | $0.9125 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 31.79 | Neutral |
| Stoch RSI (14) | 46.07 | Neutral |
| CCI (20) | -105.20 | Sell |
| Williams %R (14) | -80.88 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -18.61 | Sell |
| Bollinger %B (20,2) | 0.19 | Neutral |
| Stochastic %K (14) | 19.12 | Buy |
| TRIX (15) | -1.12 | Sell |
| Awesome (5,34) | -0.07 | Sell |
| Ultimate (7,14,28) | 26.33 | Buy |
| Momentum (10) | -0.04 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 0.20 | Buy |
| ADX (14) | 29.21 | Sell |
| ATR (14) | 0.01 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 30.
Price is trading below the SMA50 of $0.3177 and the SMA200 of $0.4449, suggesting limited near-term momentum.
Support is at $0.21 and resistance at $0.343, framing a near-term range anchored by the 30-day window from $0.1563 to $0.2826.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.21 | $0.2228 | $0.2856 | 0% | Neutral | |
| $0.141 | $0.2006 | $0.3094 | -10% | Neutral | |
| $0.1086 | $0.1662 | $0.275 | -25% | Bearish | |
| $0.1188 | $0.1936 | $0.3381 | -13% | Neutral | |
| $0.1427 | $0.2466 | $0.4501 | +11% | Neutral | |
| $0.1379 | $0.2517 | $0.4772 | +13% | Neutral | |
| $0.1315 | $0.253 | $0.4959 | +14% | Neutral | |
| $0.1205 | $0.244 | $0.4929 | +10% | Neutral | |
| $0.111 | $0.2365 | $0.4908 | +6% | Neutral | |
| $0.1018 | $0.2263 | $0.4815 | +2% | Neutral | |
| $0.144 | $0.3199 | $0.7358 | +44% | Bullish | |
| $0.2932 | $0.6516 | $1.50 | +192% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.21 | $0.2228 | $0.2708 | +0.00% |
| August 2026 | $0.1726 | $0.2109 | $0.2696 | -5.34% |
| September 2026 | $0.1748 | $0.2172 | $0.2843 | +2.99% |
| October 2026 | $0.1785 | $0.2249 | $0.3002 | +3.55% |
| November 2026 | $0.1693 | $0.2159 | $0.2929 | -4.00% |
| December 2026 | $0.1608 | $0.2074 | $0.2856 | -3.94% |
Click any year to see its month-by-month CURX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CURX is projected to trade between $0.21 and $0.2856, averaging $0.2228 — a potential gain of 0% from today's $0.2228. A consolidation phase looks the most probable path here.
Curanex Pharmaceuticals Inc's 2027 outlook centres on $0.2006, within a $0.141 to $0.3094 range. That is -10% versus the projected 2026 average. That marks a -10% change versus current levels. Price action looks broadly range-bound.
By 2028, CURX could reach as high as $0.275, with a base case around $0.1662 and support toward $0.1086 — roughly -25% from $0.2228. Expect choppier, lower action through this leg of the cycle.
Expect CURX to range from $0.1188 to $0.3381 through 2029. The $0.1936 average target implies a -13% move from current prices. That is up +17% on the projected 2028 average. Price action looks broadly range-bound.
The CURX price prediction for 2030 points to an average of $0.2466 (low $0.1427, high $0.4501) — a potential gain of +11% on today's $0.2228. A consolidation phase looks the most probable path here.
In 2031, CURX is projected to trade between $0.1379 and $0.4772, averaging $0.2517 — a potential gain of +13% from today's $0.2228. That is up +2% on the projected 2030 average. Price action looks broadly range-bound.
Curanex Pharmaceuticals Inc's 2032 outlook centres on $0.253, within a $0.1315 to $0.4959 range. That is up +1% on the projected 2031 average. That marks a +14% change versus current levels. A consolidation phase looks the most probable path here.
By 2033, CURX could reach as high as $0.4929, with a base case around $0.244 and support toward $0.1205 — roughly +10% from $0.2228. Price action looks broadly range-bound.
Expect CURX to range from $0.111 to $0.4908 through 2034. The $0.2365 average target implies a +6% move from current prices. That is -3% versus the projected 2033 average. A consolidation phase looks the most probable path here.
The CURX price prediction for 2035 points to an average of $0.2263 (low $0.1018, high $0.4815) — a potential gain of +2% on today's $0.2228. Price action looks broadly range-bound.
In 2040, CURX is projected to trade between $0.144 and $0.7358, averaging $0.3199 — a potential gain of +44% from today's $0.2228. That is up +41% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Curanex Pharmaceuticals Inc's 2050 outlook centres on $0.6516, within a $0.2932 to $1.50 range. That is up +104% on the projected 2040 average. That marks a +192% change versus current levels. Momentum favours further upside here.
Investing $1,000 in CURX today (≈ 4,488.330341 CURX) could be worth
$2,924.49
+$1,924.49 (+192%) by 2050 · US Dollar
Based on the average projected CURX price of $0.65 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CURXwould be worth at today's price.
$1,000 invested in CURX on Aug 26, 2025 (≈ 248.75622 CURX) would be worth
$55.42
-$944.58 (-94.5%) today · 0.06× · US Dollar
Based on a CURX entry price of $4.02 vs. today's $0.2228.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.255 | $873.73 | -12.6% |
| 1 month ago | $0.326 | $683.44 | -31.7% |
| 3 months ago | $0.464 | $480.17 | -52.0% |
| 6 months ago | $0.368 | $605.43 | -39.5% |
| All time ago | $4.02 | $55.42 | -94.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CURX forecast.
Our base-case forecast reaches $0.45 around 2050.
Implied market cap at $0.45: $12.75M
The year-by-year forecast shows a near-term flat start in 2026 (min $0.21, avg $0.2102, max $0.2703) with ROI 0 and a NEUTRAL sentiment.
2027 through 2029 depict bear conditions, with 2027 avg $0.189 and ROI -10.1, 2028 avg $0.1549 and ROI -26.3, and 2029 avg $0.1825 and ROI -13.2.
From 2030 onward the trajectory turns higher: 2030 avg $0.2334 (ROI 11), 2031 avg $0.2363 (ROI 12.4), 2032 avg $0.2391 (ROI 13.7), 2033 avg $0.2305 (ROI 9.6), 2034 avg $0.221 (ROI 5.1), 2035 avg $0.2127 (ROI 1.2).
Bullish momentum appears in 2040 with avg $0.2999 (ROI 42.7) and again in 2050 with avg $0.6164 (ROI 193.2), where the max reaches $0.6898 and $1.42 respectively.
Tap a question to reveal the answer.
Avg $0.2334; min $0.1334; max $0.43; ROI 11; sentiment NEUTRAL.
Forecasts show mixed returns: 2026 ROI 0 with avg $0.2102, then negative returns in 2027-2029 (ROI -10.1, -26.3, -13.2). From 2030 onward, positive momentum appears (2030 ROI 11) and, by 2040 and 2050, ROI rises to 42.7 and 193.2 respectively, with max values of $0.43 in 2030 and $1.42 in 2050.
Yes, the max forecast by 2050 is $1.42.
Current price $0.2102; Market cap $5.96M.
Sentiment NEUTRAL; RSI14 30; SMA50 $0.3177; SMA200 $0.4449; 30-day range $0.1563-$0.2826; support $0.21; resistance $0.343; annualized volatility 90.
Curanex Pharmaceuticals Inc Community Discussion
0Share your Curanex Pharmaceuticals Inc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.